All terms in GO
| Label | Id | Description |
|---|---|---|
| interleukin-35 production | GO_0070753 |
The appearance of interleukin-35 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
| regulation of interleukin-35 production | GO_0070754 |
Any process that modulates the frequency, rate, or extent of interleukin-35 production.
|
| negative regulation of cardiac muscle contraction | GO_0055118 |
Any process that stops, prevents, or reduces the frequency, rate or extent of cardiac muscle contraction.
|
| negative regulation of interleukin-35 production | GO_0070755 |
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-35 production.
|
| regulation of vascular associated smooth muscle cell dedifferentiation | GO_1905174 |
Any process that modulates the frequency, rate or extent of vascular smooth muscle cell dedifferentiation.
|
| positive regulation of interleukin-35 production | GO_0070756 |
Any process that activates or increases the frequency, rate, or extent of interleukin-35 production.
|
| negative regulation of vascular associated smooth muscle cell dedifferentiation | GO_1905175 |
Any process that stops, prevents or reduces the frequency, rate or extent of vascular smooth muscle cell dedifferentiation.
|
| interleukin-35-mediated signaling pathway | GO_0070757 |
The series of molecular signals initiated by interleukin-35 binding to its receptor on the surface of a target cell, and ending with the regulation of a downstream cellular process, e.g. transcription.
|
| RISC complex binding | GO_1905172 |
Binding to a RISC complex.
|
| eukaryotic translation initiation factor 2B complex assembly | GO_1905173 |
The aggregation, arrangement and bonding together of a set of components to form an eukaryotic translation initiation factor 2B complex.
|
| negative regulation of interleukin-35-mediated signaling pathway | GO_0070759 |
Any process that decreases the rate, frequency or extent of an interleukin-35-mediated signaling pathway.
|
| regulation of cardiac muscle tissue regeneration | GO_1905178 |
Any process that modulates the frequency, rate or extent of cardiac muscle tissue regeneration.
|
| negative regulation of cardiac muscle tissue regeneration | GO_1905179 |
Any process that stops, prevents or reduces the frequency, rate or extent of cardiac muscle tissue regeneration.
|
| positive regulation of vascular associated smooth muscle cell dedifferentiation | GO_1905176 |
Any process that activates or increases the frequency, rate or extent of vascular smooth muscle cell dedifferentiation.
|
| otolith mineralization completed early in development | GO_0031173 |
The formation of otoliths during embryogenesis with completion in early postembryonic development. Formation occurs by precipitation of specific crystal forms of calcium carbonate around an organic core of extracellular matrix proteins. Otoconia (otoliths) are small (~10 micron) dense extracellular particles present in the otolith end organs of the vertebrate inner ear.
|
| otolith mineralization | GO_0045299 |
The precipitation of specific crystal forms of calcium carbonate with extracellular matrix proteins in the otolith organs of the vertebrate inner ear.
|
| lifelong otolith mineralization | GO_0031174 |
The formation and growth of otoliths throughout the life of the organism. Otoliths are the large extracellular ear-stones of the fish inner ear, produced by precipitation of specific crystal forms of calcium carbonate on organic matrices. The otolith enlarges throughout the life of the fish, as layers of calcium carbonate are added.
|
| endo-1,4-beta-xylanase activity | GO_0031176 |
Catalysis of the endohydrolysis of (1->4)-beta-D-xylosidic linkages in xylans.
|
| phosphopantetheine binding | GO_0031177 |
Binding to phosphopantetheine, the vitamin pantetheine 4'-(dihydrogen phosphate).
|
| modified amino acid binding | GO_0072341 |
Binding to a modified amino acid.
|